SELLAS Life Sciences Group, Inc. (FRA:RXK3)
Germany flag Germany · Delayed Price · Currency is EUR
3.430
+0.030 (0.88%)
At close: Feb 20, 2026

FRA:RXK3 Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
6007131457745
Market Cap Growth
430.13%129.94%-32.37%-41.14%71.88%140.74%
Enterprise Value
5635128265539
Last Close Price
3.430.910.962.094.674.52
PS Ratio
---48.5911.5628.93
PB Ratio
15.427.73-4.2610.024.321.97
P/TBV Ratio
16.109.69-16.544.772.70
EV/Sales Ratio
---28.288.2125.15
Debt / Equity Ratio
0.010.11-0.110.200.040.04
Net Debt / Equity Ratio
-0.96-1.360.20-3.33-1.01-1.23
Net Debt / FCF Ratio
1.430.360.050.680.793.29
Asset Turnover
---0.040.210.06
Quick Ratio
7.481.460.181.104.292.86
Current Ratio
8.281.720.231.144.632.99
Return on Equity (ROE)
-84.33%-4147.88%--327.81%-85.70%-98.41%
Return on Assets (ROA)
-44.90%-153.57%-174.27%-84.58%-33.87%-33.88%
Return on Capital Employed (ROCE)
-61.40%-317.60%503.80%-588.60%-92.00%-50.40%
Earnings Yield
-3.69%-42.19%-109.87%-85.00%-23.56%-30.48%
FCF Yield
--48.37%-92.42%-49.00%-29.62%-18.95%
Buyback Yield / Dilution
-82.98%-120.33%-43.21%-25.29%-94.07%-211.76%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.